Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 119.00
Bid: 118.50
Ask: 120.00
Change: -5.00 (-4.03%)
Spread: 1.50 (1.266%)
Open: 124.00
High: 124.00
Low: 119.00
Prev. Close: 124.00
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change and Trading Update

2 May 2019 07:00

RNS Number : 8667X
McBride PLC
02 May 2019
 

2 May 2019

 

McBride plc

 

Directorate Change and Trading Update

 

Directorate Change

 

McBride plc (the "Company") announces that Rik De Vos, CEO, has informed the Board of his decision to leave the Company. A search will commence immediately and Rik has advised the Board that he will remain in position while his successor is being recruited.

 

John Coleman, Chairman, said:

"Rik has brought a strong vision and laid the foundations of the Company's transformation through the "Manufacturing our Future" strategy. I would like to take this opportunity to thank him on behalf of the Board and colleagues for his contribution. I would also like to thank Rik for agreeing to assist the Board to ensure a smooth handover of his responsibilities. The Board wishes him every success in his future endeavours."

 

Rik De Vos, CEO, said:

"In recent years, we have achieved much in a challenging trading environment. We have developed a clear strategy in "Manufacturing our Future" and delivered clear benefits from implementing the "Repair, Prepare, Grow" phases. However, I now consider that the Group requires different leadership to deliver the next phase of its growth ambitions. I'm confident that I will be leaving McBride well positioned to realise these ambitions."

 

An announcement will be made regarding Rik's successor and his departure date in due course.

 

Trading update

 

Following a weak third quarter trading period, the Group now anticipates that its full year earnings will be modestly lower than current market expectations, primarily as a result of weaker than expected sales activity in Germany, France and Italy.

 

The Group expects to provide a trading update for the 12 months ending 30 June 2019 in early July.

 

 

For further information please contact:

McBride plc

John Coleman, Chairman

Chris Smith, CFO

0161 203 7570

FTI Consulting

Ed Bridges, Nick Hasell

020 3727 1017

 

 Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

 

Addendum - CEO Remuneration disclosures

 

Salary and Benefits 

 

Rik will receive payments during his notice period of six months in accordance with his contractual entitlement namely base salary, payments in lieu of pension contributions and benefits. His benefits consist of a company car, private healthcare, disability insurance and life cover. Full details of Rik's contractual entitlements are included in the Remuneration report 2018.

 

Incentives

 

Entitlements to any bonus payment for the current financial year, unvested LTIP entitlements and unvested shares under the deferred bonus plan lapse with this resignation. Full details of unvested awards are included in the Remuneration report 2018.

 

Full details of any relevant payments will be included in the Directors' Remuneration Report for the relevant year. All payments to be made in the notice period are in accordance with the Directors' Remuneration Policy which was approved by shareholders on 24 October 2017.

 

-Ends-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGUUCAUPBUAP
Date   Source Headline
2nd Sep 20107:00 amRNSFinal Results
30th Jul 20103:47 pmRNSTotal Voting Rights
14th Jul 20102:43 pmRNSHolding(s) in Company
2nd Jul 20102:45 pmRNSDirector/PDMR Shareholding
28th Jun 20105:17 pmRNSDirector/PDMR Shareholding
24th Jun 20107:00 amRNSPre-close Trading Statement
28th May 201010:49 amRNSTotal Voting Rights
24th May 20102:49 pmRNSHolding(s) in Company
14th May 20103:06 pmRNSDirector/PDMR Shareholding
13th May 20103:36 pmRNSDirector/PDMR Shareholding
29th Apr 20107:00 amRNSInterim Management Statement
15th Apr 20107:00 amRNSAppointment of Chief Executive Officer
14th Apr 20103:25 pmRNSHolding(s) in Company
6th Apr 20103:48 pmRNSHolding(s) in Company
30th Mar 20102:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20109:12 amRNSTransaction in Own Shares
5th Mar 20103:32 pmRNSDirector/PDMR Shareholding
26th Feb 20101:40 pmRNSTotal Voting Rights
24th Feb 201012:08 pmRNSTransaction in Own Shares
24th Feb 201012:07 pmRNSDirector/PDMR Shareholding
22nd Feb 201011:55 amRNSDirector/PDMR Shareholding
18th Feb 20104:46 pmRNSDirector/PDMR Shareholding
4th Feb 20107:00 amRNSHalf Yearly Results
20th Jan 20102:52 pmRNSHolding(s) in Company
17th Dec 20097:00 amRNSPre Close Trading Statement
1st Dec 20094:11 pmRNSDirector/PDMR Shareholding
1st Dec 200912:58 pmRNSTotal Voting Rights
17th Nov 200912:31 pmRNSHolding(s) in Company
5th Nov 200910:01 amRNSHolding(s) in Company
3rd Nov 20093:15 pmRNSTotal Voting Rights
3rd Nov 20099:30 amRNSResignation of Chief Executive
27th Oct 20094:40 pmRNSResult of AGM
26th Oct 20097:00 amRNSAGM and Interim Management Statement
21st Oct 20094:11 pmRNSHolding(s) in Company
21st Oct 200910:00 amRNSCancellation of blocklisting
16th Oct 20099:57 amRNSHolding(s) in Company
12th Oct 200912:37 pmRNSAnnual Information Update
9th Oct 200910:40 amRNSShare Transactions
1st Oct 200911:06 amRNSHolding(s) in Company
30th Sep 200910:00 amRNSTotal Voting Rights
24th Sep 20093:11 pmRNSAnnual Report and Accounts
23rd Sep 200912:14 pmRNSTransaction in Own Shares
22nd Sep 200911:29 amRNSTransaction in Own Shares
17th Sep 20099:42 amRNSTotal Voting Rights
11th Sep 20095:57 pmRNSTransaction in Own Shares
7th Sep 20095:09 pmRNSDirector Appointment
3rd Sep 20097:00 amRNSPreliminary Results
3rd Aug 20097:00 amRNSAppointment of new Executive Director
27th Jul 200910:55 amRNSHolding(s) in Company
22nd Jul 200910:54 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.